IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 126-150 out of 1326.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

Public Release: 23-Sep-2015
PARSORTIX cell separation system effectively isolates CTCs indicating metastatic cancer
A new study released in PLOS ONE, demonstrates a method that allows Parsortix to capture more CTCs at comparable speeds to the existing clinical system while also overcoming the limitations of EpCAM-based approaches for detecting metastatic cancer.

Contact: Chris Anderson
Brandwidth Solutions LLC

Public Release: 23-Sep-2015
Metastatic breast cancer cells turn on stem cell genes
Scientists from UCSF describe capturing and studying individual metastatic cells from human breast cancer tumors implanted into mice as the cells escaped into the blood stream and began to form tumors elsewhere in the body.

Contact: Nicholas Weiler
University of California - San Francisco

Public Release: 22-Sep-2015
Study questions use of androgen deprivation therapy for certain prostate cancer cases
Among men with unfavorable-risk prostate cancer and moderate or severe co-existing illness, long-term follow-up finds that radiation therapy alone vs radiation therapy and androgen deprivation therapy was associated with decreased overall and cardiac mortality, according to a study in the Sept. 22/29 issue of JAMA.

Contact: Lori Schroth
The JAMA Network Journals

Public Release: 22-Sep-2015
Journal of Urology
More men at risk for prostate cancer as a result of less regular screening
The US Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate and high risk cancer diagnoses raises concern because of the potential for delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators reporting in The Journal of Urology.

Contact: Linda Gruner
Elsevier Health Sciences

Public Release: 22-Sep-2015
Scientific Reports
New smart robot accelerates cancer treatment research
A new smart research robot accelerates research on cancer treatments. The new robot system finds optimal treatment combinations. Today Scientific Reports (Nature Publishing Group) is publishing an article about the robot, authored by Dr Mats Gustafsson, Professor of Medical Bioinformatics at Uppsala University.

Contact: Mats Gustafsson
Uppsala University

Public Release: 22-Sep-2015
Androgen deprivation therapy associated with increased risk for fatal heart attack
Long term follow up of a randomized clinical trial that compared ADT and radiation therapy (RT) to RT alone finds that men with significant comorbidity; most commonly prior heart attack, who received ADT died earlier, due to a fatal heart attack, compared to men who did not receive ADT.

Contact: Lori J. Schroth
Brigham and Women's Hospital

Public Release: 22-Sep-2015
New method for testing iPSC differentiation potential could lead to safer and more potent treatments
Though the discovery of induced pluripotent stem cells (iPSCs) has great potential to help in the development of regenerative medicine therapies, the attempts to discover how safe and potent use of iPSCs are in treatment of diseases has been inconclusive or contradictory. Atlas Regeneration Inc., working together with Insilico Medicine, has developed a method for using pathway activity analysis to test for differentiation potential that makes iPSCs effective much more quickly than was previously possible.

Contact: Qingsong Zhu
InSilico Medicine, Inc.

Public Release: 22-Sep-2015
Journal of the National Cancer Institute
Two-drug combination shows promise against one type of pancreatic cancer
One form of pancreatic cancer has a new enemy: a two-drug combination discovered by UF Health researchers that inhibits tumors and kills cancer cells in mouse models.
NIH/National Cancer Institute, Florida Bankhead-Coley Cancer Research Program, Gatorade Trust

Contact: Doug Bennett
University of Florida

Public Release: 22-Sep-2015
Physics in Medicine and Biology
Tracking down the beam
Proton beams are new high-precision weapons in the fight against cancer. However, uncertainty with regard to the range of the beams has prevented the full exploitation of the potential of this method until now. Researchers are therefore looking for ways to measure the exact range during a course of treatment. Scientists at the National Center for Radiation Research in Oncology -- OncoRay and at Helmholtz-Zentrum Dresden-Rossendorf have developed a surprisingly simple solution. Initial preclinical tests have already gone well.

Contact: Simon Schmitt
Helmholtz-Zentrum Dresden-Rossendorf

Public Release: 21-Sep-2015
Deutsches Ärzteblatt International
Breast cancer: Care in Germany
Every year, more than 70,000 women in Germany develop an invasive breast tumor. This makes breast cancer the most common tumor disease in women. The current edition of Deutsches Ärzteblatt International contains no less than three articles focusing on breast cancer.

Contact: Elke Bartholomäus
Deutsches Aerzteblatt International

Public Release: 21-Sep-2015
Health Psychology Review
Study finds targeting exercise is not the best way to reduce prolonged sitting
Targeting sitting time, rather than physical activity, is the most effective way to reduce prolonged sitting, according to the first comprehensive review of strategies designed to reduce sitting time. The research, led by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, is published in the journal Health Psychology Review.

Contact: Jack Stonebridge
King's College London

Public Release: 21-Sep-2015
Canadian Medical Association Journal
Ontario shift to family health teams leads to improved diabetes care for patients
Paying doctors differently and adding other professionals to the health team has improved diabetes care for patients in Ontario, according to a new study by researchers at St. Michael's Hospital.
Canadian Institutes of Health Research

Contact: Kendra Stephenson
St. Michael's Hospital

Public Release: 21-Sep-2015
Nature Methods
Targeting DNA
MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 21-Sep-2015
Journal of Medical Screening
Over 50 percent don't go for new bowel cancer test
More than half of people invited to take a new bowel cancer screening test didn't take up the opportunity -- even though it could stop them developing or dying from the disease, according to a Cancer Research UK report published today in the Journal of Medical Screening.
Cancer Research UK

Contact: Paul Thorne
Cancer Research UK

Public Release: 21-Sep-2015
Molecular Biology of the Cell
Van Andel Research Institute, University of Toledo find way to combat brain cancer
Scientists at the University of Toledo Health Science Campus (UT) and Van Andel Research Institute (VARI) have discovered an innovative way that may stop the spread of the most lethal and aggressive brain cancer glioblastoma multiforme (GBM). In laboratory studies, scientists demonstrated that activating a specific family of proteins halted cancer cell migration into healthy tissue.

Contact: Beth Hinshaw-Hall
Van Andel Research Institute

Public Release: 21-Sep-2015
Journal of Developmental Origins of Health and Disease
Mice exposed to environmental chemicals may show decreased physical activity in offspring
Endocrine disruptors interfere with endocrine or hormone systems and can cause tumors, birth defects and developmental disorders in mammals. Now, a University of Missouri study suggests that female mice exposed to environmental chemicals may cause decreases in their daughter's metabolism and the amount of exercise in which they engage in later in life. These disruptors when introduced in developmental stages, are essentially creating 'couch potatoes' among female mice and could predict future metabolic complications.
National Institutes of Health

Contact: Jeff Sossamon
University of Missouri-Columbia

Public Release: 21-Sep-2015
Nature Communications
Scientists identify DNA alterations as among earliest to occur in lung cancer development
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest 'premalignant' genetic changes that mark the potential onset of the most common and deadliest form of disease.
NIH/National Cancer Institute

Contact: Catherine Gara
Johns Hopkins Medicine

Public Release: 21-Sep-2015
Role of cancer-suppressing gene uncovered
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer.

Contact: Professor Robert Richards
University of Adelaide

Public Release: 21-Sep-2015
Study: Brentuximab vedotin effective, safe in elderly Hodgkin lymphoma patients
A study published online in Blood, the Journal of the American Society of Hematology, reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for chemotherapy.

Contact: Amanda Szabo
American Society of Hematology

Public Release: 21-Sep-2015
Frontiers in Optics: The 99th OSA Annual Meeting
Pushing the limits of lensless imaging
Using ultrafast beams of extreme ultraviolet light streaming at a 100,000 times a second, researchers from the Friedrich Schiller University Jena, Germany, have pushed the boundaries of a well-established imaging technique. The new approach could be used to study everything from semiconductor chips to cancer cells.

Contact: Rebecca Andersen
The Optical Society

Public Release: 20-Sep-2015
Monitoring the microbiome in leukemia patients could reduce infections during chemotherapy
Researchers report that a patient's microbial diversity, even before they start cancer treatment, can be linked to risk of infection during induction chemotherapy. This research is presented at ASM's Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC/ICC).
MD Anderson Cancer Center

Contact: Aleea Khan
American Society for Microbiology

Public Release: 18-Sep-2015
PLOS Genetics
Discovery of a triple barrier that prevents cells from becoming cancerous
Universitat Autonoma de Barcelona researchers have identified for the first time a triple mechanism that stops mitosis when the integrity of the chromosomes is threatened. The activation of any of the three control pathways blocks the process that could lead to a malignant transformation. The study has been published in PLOS Genetics.

Contact: David Quintana
Universitat Autonoma de Barcelona

Public Release: 18-Sep-2015
Oral Oncology
Imaging method has potential to stratify head and neck cancer patients
Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.

Contact: Jamie Brown
University of Manchester

Public Release: 18-Sep-2015
Journal of Bone and Joint Surgery
One size doesn't fit all
Jefferson researchers identified a high risk for venous thromboembolism, or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer. They published the results in the Journal of Bone and Joint Surgery.

Contact: Gail Benner
Thomas Jefferson University

Public Release: 18-Sep-2015
Molecular Oncology
Western University hopes to use artificial intelligence to improve breast cancer patient outcomes
Western University researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy medications used to treat breast cancer -- paclitaxel and gemcitabine. Peter Rogan, Ph.D., and a team of researchers, including Stephanie Dorman, Ph.D., and Katherina Baranova, B.M.Sc., at Western's Schulich School of Medicine & Dentistry, are hoping to one day remove the guesswork from breast cancer treatment with this technique.

Contact: Tristan Joseph
519-661-2111 x80387
University of Western Ontario

Showing releases 126-150 out of 1326.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

  Search News Releases